Work

A Phase II, Single-arm Trial of Sunitinib and Erlotinib in Advanced Renal Cell Carcinoma

Year: 2022

Type: article

Study design: Clinical Trial

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2022.04.018

Authors: Zizhen Feng, Brendan D. Curti, David I. Quinn, John M. Strother, Zunqiu Chen, Rebecca Agnor, Tomasz M. Beer, Christopher W. Ryan

Institutions: OHSU Knight Cancer Institute, Providence Portland Medical Center, USC Norris Comprehensive Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Astellas Pharma US, Pfizer UK

OpenAlex ID: W4229067039

FWCI: 0.322

Cites: 29

Cited by: 2

Related to: 10